Which Go-to-Market Channel Actually Pays Back for Healthtech? A Unit Economics Approach
Direct answer: For healthtech and digital health, the go-to-market channel that "pays back" is the one where fully-loaded acquisition cost is recovered inside your cash runway and accounts for the sales cycle, reimbursement lag, and regulatory friction unique to health buyers. You find it by calculating unit economics per channel — CAC, gross margin per member/patient, payback period, and lifetime value — not by comparing raw lead volume or cost-per-click. The channel with the shortest risk-adjusted payback and the highest LTV/CAC usually wins, but in healthtech that answer is often counterintuitive because enterprise and payer channels have long cycles and strong retention while consumer channels have fast cycles and high churn.
Why generic channel math breaks in healthtech
Most channel-mix advice assumes a clean loop: spend on ads, get signups, monetize. Digital health rarely works that way. Your revenue may come from a self-insured employer, a health plan, a provider system, or a patient paying out of pocket — and each of those buyers has a completely different cost, cycle, and margin structure.
A few realities that distort channel economics in this industry:
- Reimbursement lag. Revenue recognized in month one may not convert to collected cash for 90–180 days if you bill through payers.
- Regulatory and procurement friction. Enterprise health buyers require security reviews, HIPAA/BAA execution, and clinical validation. That extends the sales cycle and inflates true CAC well beyond media spend.
- Split economics of two-sided models. If patients are the users but employers or payers are the buyers, "cost to acquire a user" and "cost to acquire a contract" are different numbers that must both be tracked.
- Clinical outcomes as a gating factor. A channel that acquires cheap, low-engagement members can crush your outcomes data and jeopardize contract renewals — killing LTV even when CAC looks great.
This is why cost-per-lead comparisons mislead. The right lens is unit economics per channel, carried all the way through to gross margin and retained cash.
Applying the Unit Economics framework, channel by channel
Run each channel — payer partnerships, provider/health-system sales, self-insured employers, direct-to-consumer, PLG/app store, and channel partners — through the same structured questions.
Step 1 — Define the unit. Decide whether your unit is a paying member, an enrolled patient, or a signed contract. In health, you often need two units: acquired contract and acquired active member, because a signed employer means nothing if utilization is low.
Step 2 — Calculate fully-loaded CAC per channel. Include media, sales headcount (loaded salary + commission), implementation and onboarding cost, security/compliance work required to close, and clinical validation spend attributable to that channel. For payer and enterprise channels, allocate the real cost of a 6–18 month sales motion.
Step 3 — Establish gross margin per unit. Subtract cost to serve: clinical staff time, care coordination, platform/hosting, and any per-visit or per-claim cost. Healthtech gross margins vary enormously — a software-only tool and a virtual-care service with clinicians attached are not comparable.
Step 4 — Model retention and LTV honestly. Use cohort retention, not blended averages. Employer and payer contracts often retain for years but face annual re-bids; DTC subscriptions may churn quickly. Multiply gross margin per period by expected retained periods to get LTV.
Step 5 — Compute payback period and LTV/CAC. Payback = fully-loaded CAC ÷ monthly gross margin per unit. Then risk-adjust for reimbursement lag and contract concentration.
What "good" looks like:
- Payback period shorter than your cash runway — and ideally under 12–18 months for enterprise/payer, faster for DTC where churn is higher.
- LTV/CAC meaningfully above 3:1 on a gross-margin basis, not revenue.
- Cash-adjusted payback that accounts for the gap between recognized and collected revenue.
- Cohort stability — retention that holds or improves as you scale the channel, not one that decays as you exhaust the cheap early adopters.
A channel that looks efficient on CAC but has 40% first-year churn and 90-day cash lag can be worse than a slower, more expensive payer channel with multi-year retention. Only the unit economics reveal that.
Turning the analysis into a channel decision
Once you have the numbers per channel, the decision is straightforward in principle: concentrate spend where risk-adjusted payback is fastest and LTV/CAC is strongest, then stage the slower-but-durable channels behind them. The hard part is doing the calculation rigorously and pressure-testing it against scenarios — what if reimbursement rates change, what if a large contract doesn't renew, what if CAC inflates as you scale?
When a spreadsheet or a human consultant is enough: If you have one or two channels and clean data, a well-built spreadsheet is genuinely sufficient — don't over-engineer this. If your core challenge is strategic and messy (repositioning, a payer-contract negotiation, or a board fight over which markets to enter), an experienced healthtech advisor or fractional CFO who has lived through reimbursement cycles will add judgment no tool replaces.
When a platform helps: If you're comparing five-plus channels, running multiple scenarios, and need board-ready output on a tight timeline, that's where structured analysis at speed matters. Percision — the Strategic Intelligence Platform, which I help build content for — runs your business context through its Unit Economics framework alongside 26 others, producing channel-level payback models, scenario analyses, and an Excel-exportable model with an audit trail in minutes rather than weeks. It's explicitly a co-pilot, not an autopilot: your leadership team still owns the assumptions and the call. Independent research such as the BCG–Harvard Business School field experiment on generative AI and knowledge work (2023) suggests AI tools improve speed and quality on well-scoped analytical tasks — but they don't replace domain judgment about payer dynamics or clinical risk.
You can pressure-test your channel-mix economics at percision.app.
What this looks like when the analysis is actually run
The employer channel, by a wide margin — because its acquisition work was already paid for by the health-plan channel.
The subject is Vantabridge Health, a sample company profile we use for testing rather than a customer: a virtual chronic-care platform, $62M revenue, 340,000 enrolled members.
Excerpt from a real Percision run · Pricing Strategy (T2) · sample company profile
The payback. $0.6–0.9M of investment — 2 FTE employer specialists at $180K fully loaded over 18 months plus $120K of enablement tools — returning 13.0×, with $3.9M of employer outcomes revenue by Month 12 and $11.7M cumulative by Month 24.
Why the cycle collapses. The 180 employers sit inside existing health-plan relationships, so the 11-month sales cycle is bypassed in favour of a 4–6 month upsell, on the same A1c, blood-pressure and admission metrics already proven with health plans.
The unit that has to improve. Employer engagement at 45% or better against a current 41%, and device-kit leakage from 59% to 35% of the enrolled base by shifting kit cost to employer opt-in — against $6.5M of kit cost.
What the other channel contributes. 34 contracts, 71% of revenue, 48-month durability — repriced to a 25% cap at $0 incremental investment for a 5.2× return and $2.9M of gross profit protected annually.
The termination line. Employer conversion below 25% by Month 12, or at-risk share demanded above 50%.
| Metric | Target | By |
|---|---|---|
| Employer outcomes revenue | $3.9M by Month 12, $11.7M by Month 24 | Month 24 |
| Employer engagement rate | ≥45% (vs current 41%) | Month 18 |
| Device-kit leakage on employer cohort | ≤35% (vs current 59%) | Month 18 |
| Blended at-risk share across employer book | 45% (vs 38% payer average) | Month 24 |
Thirteen times on $0.9M is the headline, but the number that makes it real is the 25% conversion floor. Converting 45 of 180 employers who already receive the service is not an aggressive assumption, and the plan stops if it is missed.
Device-kit leakage is the unit-economics story underneath. Fifty-nine percent of kits go to members who never engage; moving that cost to an employer opt-in decision is the difference between a channel that scales and one that gets more expensive per member as it grows.
Read a complete Percision report — every page, no email required.
FAQ
Should healthtech use revenue or gross margin to calculate LTV/CAC? Always gross margin. Health services carry real cost-to-serve (clinicians, care coordination, per-claim cost). A revenue-based LTV/CAC will flatter channels that are actually margin-thin once you account for delivery.
How do I account for reimbursement lag in payback? Model cash-adjusted payback: shift recognized gross margin forward by your average collection period. A channel with a 90–180 day lag has a longer real payback than its accounting numbers imply, which matters most when runway is tight.
Is DTC or payer/enterprise the better channel for digital health? Neither is universally better — it depends on your unit economics. DTC offers fast cycles but higher churn; payer and enterprise offer durable retention but long, expensive sales motions. Run both through the same framework and compare risk-adjusted payback before committing spend.